MAYO POSITIVE FOR EPO AT TOUR
Spanish Climber Iban Mayo tested positive for banned blood boosting drug EPO during the Tour de France, it was announced on Monday night via a press release (in full below) issued by his team, Saunier Duval.
Mayo is a team-mate of Britain's David Millar, and has in the past been outspoken in his criticism of doping in professional cycling. The Spaniard has been suspended by the team pending the results of tests on his B sample.
Mayo was tested during the second rest day in the Pyrenees. The sample returned a positive for erythropoietin (EPO), which stimulates the body to produce more red blood cells, enabling more oxygen to be carried to muscles and therefore better performance in the mountains.
It's the latest drug-related scandal to hit a high profile rider at this year's event, and yet another body blow to the Tour.
Mayo's positive test for EPO joins Alexandre Vinokourov's positive for blood transfusion and Cristian Moreni's positive for testosterone during the race. Patrik Sinkewitz was also excluded from the race as it was announced during the event that he had tested positive for testosterone in June.
Michael Rasmussen was also sensationally sacked by his Rabobank squad and kicked out of the race whilst in the leader's jersey for lying about his whereabouts during training in June. He missed four out-of-competition dope controls, and had told his team that this was due to communication problems as he was training in Mexico, but it later transpired that he was in Italy at the time.
Mayo finished the 2007 Tour in 16th place overall.
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
Saunier Duval's official statement in full:
OFFICIAL STATEMENT
SAUNIER DUVAL-PRODIR team official statement.
30/07/2007
The SAUNIER DUVAL-PRODIR team were notified by the International Cycling Union (UCI) that Iban Mayo had tested positive for EPO following a test on July 24, which was a rest day on the Tour de France.
In line with the fight against doping that the team fully support, the rider was immediately suspended without pay until the B sample has been tested. If this is confirmed as positive as well, the team will proceed to rescind his contract.
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Nigel Wynn worked as associate editor on CyclingWeekly.com, he worked almost single-handedly on the Cycling Weekly website in its early days. His passion for cycling, his writing and his creativity, as well as his hard work and dedication, were the original driving force behind the website’s success. Without him, CyclingWeekly.com would certainly not exist on the size and scale that it enjoys today. Nigel sadly passed away, following a brave battle with a cancer-related illness, in 2018. He was a highly valued colleague, and more importantly, an exceptional person to work with - his presence is sorely missed.
-
We rode and reviewed the Ouray, Parlee Cycles' first new bike model since facing bankruptcy
The storied American brand continues with a Portugal-made carbon steed that goes zoom but doesn’t fit like a race bike
By Tyler Boucher Published
-
Forget distance covered, these are the key stats to note in your Strava Year in Sport
We asked a coach how to best analyse our end of year Strava data
By Tom Davidson Published